Compare J.B.Chemicals with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PANACEA BIOTECH - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PANACEA BIOTECH J.B.CHEMICALS/
PANACEA BIOTECH
 
P/E (TTM) x 17.0 11.2 151.7% View Chart
P/BV x 2.3 2.4 99.0% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 J.B.CHEMICALS   PANACEA BIOTECH
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
PANACEA BIOTECH
Mar-19
J.B.CHEMICALS/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs363354 102.7%   
Low Rs255138 184.5%   
Sales per share (Unadj.) Rs169.174.6 226.8%  
Earnings per share (Unadj.) Rs16.66.7 248.5%  
Cash flow per share (Unadj.) Rs23.415.5 151.1%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs172.557.2 301.5%  
Shares outstanding (eoy) m83.5761.25 136.4%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.83.3 55.4%   
Avg P/E ratio x18.636.8 50.6%  
P/CF ratio (eoy) x13.215.9 83.2%  
Price / Book Value ratio x1.84.3 41.7%  
Dividend payout %12.00-   
Avg Mkt Cap Rs m25,82715,061 171.5%   
No. of employees `0003.82.3 163.0%   
Total wages/salary Rs m2,5111,471 170.7%   
Avg. sales/employee Rs Th3,747.41,973.6 189.9%   
Avg. wages/employee Rs Th665.7635.6 104.7%   
Avg. net profit/employee Rs Th367.8176.8 208.0%   
INCOME DATA
Net Sales Rs m14,1354,567 309.5%  
Other income Rs m36645 816.5%   
Total revenues Rs m14,5014,612 314.4%   
Gross profit Rs m2,1782,030 107.3%  
Depreciation Rs m570540 105.5%   
Interest Rs m351,048 3.3%   
Profit before tax Rs m1,940486 398.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m55277 716.3%   
Profit after tax Rs m1,387409 339.1%  
Gross profit margin %15.444.4 34.7%  
Effective tax rate %28.515.9 179.6%   
Net profit margin %9.89.0 109.6%  
BALANCE SHEET DATA
Current assets Rs m10,4702,415 433.6%   
Current liabilities Rs m2,7499,077 30.3%   
Net working cap to sales %54.6-145.9 -37.4%  
Current ratio x3.80.3 1,431.9%  
Inventory Days Days5565 84.8%  
Debtors Days Days7871 109.5%  
Net fixed assets Rs m5,8118,333 69.7%   
Share capital Rs m16761 272.6%   
"Free" reserves Rs m14,2483,443 413.9%   
Net worth Rs m14,4163,504 411.4%   
Long term debt Rs m0461 0.0%   
Total assets Rs m17,64913,755 128.3%  
Interest coverage x56.61.5 3,864.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.3 241.2%   
Return on assets %8.110.6 76.1%  
Return on equity %9.611.7 82.4%  
Return on capital %13.738.7 35.4%  
Exports to sales %020.9 0.0%   
Imports to sales %08.1 0.0%   
Exports (fob) Rs mNA954 0.0%   
Imports (cif) Rs mNA372 0.0%   
Fx inflow Rs m6,1641,203 512.4%   
Fx outflow Rs m1,334467 286.0%   
Net fx Rs m4,829736 655.8%   
CASH FLOW
From Operations Rs m1,2311,049 117.3%  
From Investments Rs m-208-54 389.0%  
From Financial Activity Rs m-595-1,011 58.8%  
Net Cashflow Rs m427-20 -2,168.0%  

Share Holding

Indian Promoters % 55.4 74.5 74.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.6 565.0%  
FIIs % 3.9 1.3 300.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 23.6 156.8%  
Shareholders   30,437 10,259 296.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DR. REDDYS LAB  IPCA LABS  ASTRAZENECA PHARMA  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Flat; L&T and Tech Mahindra Top Losers(12:30 pm)

Share markets in India are presently trading on a volatile note. Sectoral indices are trading mixed with stocks in the capital goods sector and realty sector.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Nov 13, 2019 12:21 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - PANACEA BIOTECH COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS